Exclusive: EU could pay over $10 billion for Pfizer and CureVac vaccines - (Fidelity via NewsPoints Desk)

• According to an official involved in the talks, the EU could pay more than $10 billion to secure hundreds of millions of doses of COVID-19 vaccines being developed by Pfizer-BioNTech and CureVac, as reported in Fidelity.

• The official said the bloc has agreed to pay €15.50 per dose for the vaccine being developed by Pfizer and BioNTech

• That would mean an overall price of up to €3.1 billion for 200 million doses, rising to €4.65 billion if another optional 100 million doses are purchased under the deal, the source said.

• The official noted that in a separate deal, the EU has agreed to pay €10 per dose for an initial supply of 225 million doses of CureVac's candidate, a discount from the €12 the company had set as the price.

• The bloc struck the deal with CureVac this week to secure the supply of up to 405 million doses, of which 180 million are optional.

• The official said CureVac had committed to starting deliveries by the end of March, although it is unclear whether the additional 180 million doses would cost €10 or €12 each. At €10 per dose, the bloc would pay €4.05 billion for 405 million doses.

To read more NewsPoints articles, click here.